Cathie Wood's position in Beam Therapeutics is currently worth $349 Million. That's 2.09% of their equity portfolio (14th largest holding). The investor owns 11.93% of the outstanding Beam Therapeutics stock. The investor's estimated purchase price is $687 Million, resulting in a loss of 49%.
Summary List Placement Cathie Wood''s Ark Invest ETFs surged on Monday following the landmark results of Intellia Therapeutics'' genomic editing clinical tri...Business Insider Markets, 12 months ago